4//SEC Filing
Harris Erik 4
Accession 0000950170-24-113249
CIK 0001693011other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:37 PM ET
Size
5.3 KB
Accession
0000950170-24-113249
Insider Transaction Report
Form 4
Harris Erik
Director
Transactions
- Award
Stock Option (right to buy)
2024-10-03+56,000→ 56,000 totalExercise: $5.06Exp: 2034-10-02→ Common Stock (56,000 underlying)
Footnotes (1)
- [F1]The option was granted on October 3, 2024. The shares underlying the option are scheduled to vest in equal monthly installments from October 3, 2024 through October 3, 2027
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001780113
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:37 PM ET
- Size
- 5.3 KB